Category: Industry Press Releases

Abbott Receives U.S. Approval of Next-generation MitraClip G4

July 25, 2019

The latest approval for the fourth-generation MitraClip device, MitraClip G4, puts new enhancements into the hands of physicians across the U.S. by delivering an expanded range of clip sizes, an alternative leaflet grasping feature and facilitation of procedure assessment in real time to offer doctors further options when treating mitral valve disease.

Visit Website

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 15, 2019

DANVERS, Mass.–(BUSINESS WIRE)–May 13, 2019– Abiomed (NASDAQ:ABMD) announces the U.S. FDA has approved the expansion of the Impella 5.0 and Impella LD PMA labeling for the treatment of cardiogenic shock. The expansion extends the duration of support for each pump from 6 days to 14 days. The Impella 5.0 and the Impella LD are forward flow heart pumps that deliver up to 5…

Read Article

BD Announces Launch of UltraScore™ 014 Focused Force PTA Balloon

April 25, 2019

FRANKLIN LAKES, N.J., April 1, 2019 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of the UltraScore™ 014 Focused Force PTA Balloon. This marks the first scoring balloon with sheath compatibility as small as 4 French on the U.S. market.

Visit Website
Page 1 of 1312345...10...»